Aventis to exit JV with Novartis | business | Hindustan Times
Today in New Delhi, India
Jul 27, 2017-Thursday
-°C
New Delhi
  • Humidity
    -
  • Wind
    -

Aventis to exit JV with Novartis

Drug-maker Aventis Pharma on Monday said it will sell its 49% stake in Chiron Behring Vaccines Pvt Ltd to its joint venture partner, Novartis Vaccines & Diagnostics Inc, for $22.4 million (nearly Rs 100 cr).

business Updated: Dec 13, 2010 22:04 IST

Drug-maker Aventis Pharma on Monday said it will sell its 49% stake in Chiron Behring Vaccines Pvt Ltd to its joint venture partner, Novartis Vaccines & Diagnostics Inc, for $22.4 million (nearly Rs 100 cr). PTI

Sanofi extends Genzyme offer

Paris: Sanofi-Aventis has extended its snubbed $18.5 billion cash bid for US biotech group Genzyme by six weeks, buying time to persuade its reluctant target to talk. Sanofi has said it won’t raise its bid unless Genzyme’s board is willing to talk. Reuters